1. Progression free survival demonstrates poor-correlation with measures of health related quality of life (HRQoL) in oncology trials. 2. Current study demonstrate poor follow-up and reporting of HRQoL measures, likely introducing bias into published results. Evidence Rating Level:3 (Average) Study Rundown: Current stated goals for the American Society of Clinical Oncology include the focus on […]